Antonio Colamaria
Overview
Explore the profile of Antonio Colamaria including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
123
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Carbone F, Fochi N, Di Perna G, Wagner A, Schlegel J, Ranieri E, et al.
Diagnostics (Basel)
. 2025 Feb;
15(4).
PMID: 40002650
Brain tumors, both primary and metastatic, represent a significant global health burden due to their high incidence, mortality, and the severe neurological deficits they frequently cause. Gliomas, especially high-grade gliomas...
2.
Lazzari G, Montagna A, Benevento I, DAndrea B, Metallo V, Tucciariello R, et al.
Cancer Manag Res
. 2025 Feb;
17:349-355.
PMID: 39990275
Objective: Primary spinal cord Glioblastoma multiforme (IV grade WHO), also known as Primary Spinal Cord Astrocytoma (SCA), accounts for 6-8% of primary spinal cord tumors and up to 1.5% of...
3.
Carbone F, Colangelo M, Corrivetti F, Colamaria A, Leone A, Corvino S, et al.
World Neurosurg
. 2025 Feb;
196:123819.
PMID: 39987974
Background: Contact endoscopy (CE) is a visualization technique with high magnification power, facilitating the in vivo examination of biological tissue morphology during different endoscopic-assisted procedures. Although its widespread implementation remains...
4.
Leone A, Di Napoli V, Fochi N, Di Perna G, Spetzger U, Filimonova E, et al.
Diagnostics (Basel)
. 2025 Feb;
15(3).
PMID: 39941181
: The methylation status of the O6-methylguanine-DNA methyltransferase (MGMT) promoter in gliomas has emerged as a critical biomarker for prognosis and treatment response. Conventional methods for assessing MGMT promoter methylation,...
5.
Leone A, Carbone F, Spetzger U, Vajkoczy P, Raffa G, Angileri F, et al.
Front Oncol
. 2025 Jan;
14():1481430.
PMID: 39839770
Accurate preoperative mapping is crucial for maximizing tumor removal while minimizing damage to critical brain functions during brain tumor surgery. Navigated transcranial magnetic stimulation (nTMS), magnetoencephalography (MEG), and functional magnetic...
6.
Ricciuti R, Mancini F, Guzzi G, Marruzzo D, Dario A, Della Puppa A, et al.
Brain Spine
. 2024 May;
4:102796.
PMID: 38698806
Introduction: Intraoperative Neurophysiological Monitoring (IOM) is widely used in neurosurgery but specific guidelines are lacking. Therefore, we can assume differences in IOM application between Neurosurgical centers. Research Question: The section...
7.
Corvino S, Kassam A, Piazza A, Corrivetti F, Spiriev T, Colamaria A, et al.
Neurosurg Focus
. 2024 Apr;
56(4):E7.
PMID: 38560942
Objective: The superior eyelid endoscopic transorbital approach (SETOA) provides a direct and short minimally invasive route to the anterior and middle skull base. Nevertheless, it uses a narrow corridor that...
8.
Colamaria A, Leone A, Carbone F, Dallos Laguado Y, Fochi N, Sacco M, et al.
J Clin Med
. 2023 Dec;
12(24).
PMID: 38137585
Background: Primary anaplastic-lymphoma-kinase (ALK)-positive large-cell lymphoma of the central nervous system (PCNS ALK-positive ALCL) is a rare entity, with a limited consensus reached regarding its management. While this pathology often...
9.
Carbone F, Colamaria A, Corvino S, Sacco M, Iaconetta G, Corrivetti F, et al.
World Neurosurg
. 2023 Dec;
182:e657-e665.
PMID: 38070736
Background: Originally adopted for the cytological screening of cervical and uterine cancer, contact endoscopy (CE) is now widely used in several fields of oncological surgery. The CE method, with magnification...
10.
Colamaria A, Leone A, Fochi N, Di Napoli V, Giordano G, Landriscina M, et al.
Surg Neurol Int
. 2023 Dec;
14:394.
PMID: 38053701
Background: This review focuses on the recently published evidence on tumor treating fields (TTFields) administered alone or in combination with locoregional and systemic options for treating glioblastoma (GBM) in the...